JACC. Heart failure最新文献

筛选
英文 中文
Sex Differences in Efficacy of Multidomain Rehabilitation Among Older Adults With Acute HF 老年急性心衰患者多领域康复疗效的性别差异:REHAB-HF试验。
IF 11.8 1区 医学
JACC. Heart failure Pub Date : 2025-09-24 DOI: 10.1016/j.jchf.2025.102547
Ambarish Pandey MD, MS , Olivia N. Gilbert MD , Dalane W. Kitzman MD , Alain G. Bertoni MD , Pamela W. Duncan PT, PhD , Robert J. Mentz MD , Gordon R. Reeves MD , David J. Whellan MD , M. Benjamin Nelson MS , Haiying Chen PhD , Vinayak Subramanian MD , Shelby D. Reed PhD , Bharati Upadhya MD , Christopher M. O’Connor MD , Amy M. Pastva PT, PhD
{"title":"Sex Differences in Efficacy of Multidomain Rehabilitation Among Older Adults With Acute HF","authors":"Ambarish Pandey MD, MS ,&nbsp;Olivia N. Gilbert MD ,&nbsp;Dalane W. Kitzman MD ,&nbsp;Alain G. Bertoni MD ,&nbsp;Pamela W. Duncan PT, PhD ,&nbsp;Robert J. Mentz MD ,&nbsp;Gordon R. Reeves MD ,&nbsp;David J. Whellan MD ,&nbsp;M. Benjamin Nelson MS ,&nbsp;Haiying Chen PhD ,&nbsp;Vinayak Subramanian MD ,&nbsp;Shelby D. Reed PhD ,&nbsp;Bharati Upadhya MD ,&nbsp;Christopher M. O’Connor MD ,&nbsp;Amy M. Pastva PT, PhD","doi":"10.1016/j.jchf.2025.102547","DOIUrl":"10.1016/j.jchf.2025.102547","url":null,"abstract":"<div><h3>Background</h3><div>A multidomain physical rehabilitation intervention (REHAB-HF [Rehabilitation Therapy in Older Acute Heart Failure Patients] intervention) has been associated with significant improvements in physical function and quality of life (QOL) among older patients with acute decompensated heart failure (ADHF).</div></div><div><h3>Objectives</h3><div>This study aims to evaluate sex differences in the treatment effect of a multidomain rehabilitation intervention among participants of the REHAB-HF trial.</div></div><div><h3>Methods</h3><div>In this prespecified secondary analysis of the REHAB-HF trial, sex differences in the treatment effect of the REHAB-HF intervention (vs attention control) on key 3-month outcomes of the Short Physical Performance Battery (SPPB, primary), frailty burden, 6-minute walking distance (6MWD), and QOL were assessed. Statistical significance for treatment effect interaction (sex∗intervention) was set at 0.1.</div></div><div><h3>Results</h3><div>Among the 349 trial participants, female patients (n = 183) had a significantly lower baseline SPPB score and 6MWD and a higher frailty burden than male patients (n = 166). Female (vs male) participants had a significantly greater improvement in SPPB (effect size: 1.9 [95% CI: 1.1-2.7] vs 1.0 [95% CI: 0.1-1.8]; <em>P</em> for interaction = 0.1) and frailty burden, as assessed by Fried phenotype criteria (effect size: −0.5 [95% CI: −0.9 to −0.2] vs 0.00 [95% CI: −0.4 to 0.4]; <em>P</em> for interaction = 0.04) with the REHAB-HF intervention. The magnitude of the improvement in 6MWD and QOL (Kansas City Cardiomyopathy Questionnaire score) with the REHAB-HF intervention was also greater among female (vs male) participants without a significant treatment effect interaction by sex. There was no significant difference in rates of adverse clinical outcomes associated with the intervention across both sex groups. There was no difference in intervention adherence by sex.</div></div><div><h3>Conclusions</h3><div>Female (vs male) participants with ADHF had a significantly greater improvement in physical function in response to the REHAB-HF intervention.</div></div>","PeriodicalId":14687,"journal":{"name":"JACC. Heart failure","volume":"13 11","pages":"Article 102547"},"PeriodicalIF":11.8,"publicationDate":"2025-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145130877","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of Glucagon-Like Peptide 1 Receptor Agonist Initiation in Patients With Heart Failure With Reduced Ejection Fraction and Implantable Cardiac Devices 胰高血糖素样肽1受体激动剂在心力衰竭伴射血分数降低和植入式心脏装置患者中的作用
IF 11.8 1区 医学
JACC. Heart failure Pub Date : 2025-09-23 DOI: 10.1016/j.jchf.2025.102573
Pedro Marques MD, MSc , Christoforos K. Travlos MD , Paula Matias MD , João Sérgio Neves MD, PhD , Michael A. Tsoukas MD , Thomas A. Mavrakanas MD , Jacqueline Joza MD , João Pedro Ferreira MD, PhD , Abhinav Sharma MD, PhD
{"title":"Effects of Glucagon-Like Peptide 1 Receptor Agonist Initiation in Patients With Heart Failure With Reduced Ejection Fraction and Implantable Cardiac Devices","authors":"Pedro Marques MD, MSc ,&nbsp;Christoforos K. Travlos MD ,&nbsp;Paula Matias MD ,&nbsp;João Sérgio Neves MD, PhD ,&nbsp;Michael A. Tsoukas MD ,&nbsp;Thomas A. Mavrakanas MD ,&nbsp;Jacqueline Joza MD ,&nbsp;João Pedro Ferreira MD, PhD ,&nbsp;Abhinav Sharma MD, PhD","doi":"10.1016/j.jchf.2025.102573","DOIUrl":"10.1016/j.jchf.2025.102573","url":null,"abstract":"<div><h3>Background</h3><div>Glucagon-like peptide 1 receptor agonists (GLP1RAs) may increase heart rate in patients with heart failure with reduced ejection fraction (HFrEF), which could induce deleterious effects in this population. Information retrieved from implanted cardiac devices may provide more insights into GLP1RA-associated effects on heart rate and arrhythmic events.</div></div><div><h3>Objectives</h3><div>This study aims to analyze the effects of GLP1RA on device-related rhythm parameters in patients with HFrEF and implanted cardiac devices.</div></div><div><h3>Methods</h3><div>The authors performed a retrospective analysis of outpatients with HFrEF with implanted cardiac devices followed in cardiorenal clinics from a single-center quaternary care hospital in Canada. GLP1RA users were compared with GLP1RA nonusers with similar baseline characteristics for longitudinal changes (1-year follow-up) in heart rate, using data from electrophysiology interrogation reports. Secondary endpoints included relevant arrhythmic events, changes in body mass index (BMI), and laboratory biomarkers.</div></div><div><h3>Results</h3><div>Among 253 patients with HFrEF and implanted cardiac devices, 53 new GLP1RA users were compared with 53 GLP1RA nonusers. The mean age was 66 ± 10 years, 81% were men, 93% had diabetes, and 36% had atrial fibrillation. The mean BMI was 31.4 kg/m<sup>2</sup>, and the mean ejection fraction was 28% ± 10%. After adjustment, GLP1RA use (vs no use) significantly increased heart rate by +7 beats/min (95% CI: 4-10 beats/min; <em>P &lt;</em> 0.01). GLP1RA use (vs no use) was associated with a numeric increase in ventricular tachycardia/fibrillation events (13 vs 2; <em>P =</em> 0.07) and a significant increase in nonsustained ventricular events and total shock/antitachycardia pacing therapies (33 vs 3; <em>P =</em> 0.01).</div></div><div><h3>Conclusions</h3><div>In this retrospective analysis of patients with HFrEF and implanted cardiac devices, GLP1RA use was associated with significant increase in heart rate and increased number of nonsustained ventricular events and total shock/antitachycardia pacing therapies. These findings highlight the need for further evaluation of GLP1RA use in HFrEF.</div></div>","PeriodicalId":14687,"journal":{"name":"JACC. Heart failure","volume":"13 11","pages":"Article 102573"},"PeriodicalIF":11.8,"publicationDate":"2025-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145106791","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Iron Deficiency Definition and Management in Patients With Heart Failure 心力衰竭患者缺铁的定义和处理
IF 11.8 1区 医学
JACC. Heart failure Pub Date : 2025-09-23 DOI: 10.1016/j.jchf.2025.102639
Pedro Marques MD, João Pedro Ferreira MD, PhD
{"title":"Iron Deficiency Definition and Management in Patients With Heart Failure","authors":"Pedro Marques MD,&nbsp;João Pedro Ferreira MD, PhD","doi":"10.1016/j.jchf.2025.102639","DOIUrl":"10.1016/j.jchf.2025.102639","url":null,"abstract":"","PeriodicalId":14687,"journal":{"name":"JACC. Heart failure","volume":"13 11","pages":"Article 102639"},"PeriodicalIF":11.8,"publicationDate":"2025-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145118808","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Improvement in Biomarkers and Freedom From Hospitalization in Bariatric Surgery Patients With Heart Failure 心力衰竭减肥手术患者生物标志物的改善和住院自由
IF 11.8 1区 医学
JACC. Heart failure Pub Date : 2025-09-22 DOI: 10.1016/j.jchf.2025.102674
Michael Foster MD , Amine Al Soueidy MD , Joshua M. Riley MD , Sara Badenhausen MD , Suveeksha Naidu , Noel Williams MD , Yevgeniy Brailovsky DO, MSc , Rene J. Alvarez MD , Kristoffel Dumon MD , J. Eduardo Rame MD, MPhil
{"title":"Improvement in Biomarkers and Freedom From Hospitalization in Bariatric Surgery Patients With Heart Failure","authors":"Michael Foster MD ,&nbsp;Amine Al Soueidy MD ,&nbsp;Joshua M. Riley MD ,&nbsp;Sara Badenhausen MD ,&nbsp;Suveeksha Naidu ,&nbsp;Noel Williams MD ,&nbsp;Yevgeniy Brailovsky DO, MSc ,&nbsp;Rene J. Alvarez MD ,&nbsp;Kristoffel Dumon MD ,&nbsp;J. Eduardo Rame MD, MPhil","doi":"10.1016/j.jchf.2025.102674","DOIUrl":"10.1016/j.jchf.2025.102674","url":null,"abstract":"","PeriodicalId":14687,"journal":{"name":"JACC. Heart failure","volume":"13 11","pages":"Article 102674"},"PeriodicalIF":11.8,"publicationDate":"2025-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145106792","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Beyond Hospitalizations 除了住院
IF 11.8 1区 医学
JACC. Heart failure Pub Date : 2025-09-20 DOI: 10.1016/j.jchf.2025.102653
Anique Ducharme MD, MS , Jonathan W. Cunningham MD, MPH
{"title":"Beyond Hospitalizations","authors":"Anique Ducharme MD, MS ,&nbsp;Jonathan W. Cunningham MD, MPH","doi":"10.1016/j.jchf.2025.102653","DOIUrl":"10.1016/j.jchf.2025.102653","url":null,"abstract":"","PeriodicalId":14687,"journal":{"name":"JACC. Heart failure","volume":"13 11","pages":"Article 102653"},"PeriodicalIF":11.8,"publicationDate":"2025-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145097356","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
GLP-1 Receptor Agonists in Heart Failure With Reduced Ejection Fraction? GLP-1受体激动剂治疗心力衰竭伴射血分数降低?更快的心率,所以不是那么快。
IF 11.8 1区 医学
JACC. Heart failure Pub Date : 2025-09-18 DOI: 10.1016/j.jchf.2025.102642
Sheldon E. Litwin MD , Mark H. Drazner MD, MSc , Andrea M. Russo MD
{"title":"GLP-1 Receptor Agonists in Heart Failure With Reduced Ejection Fraction?","authors":"Sheldon E. Litwin MD ,&nbsp;Mark H. Drazner MD, MSc ,&nbsp;Andrea M. Russo MD","doi":"10.1016/j.jchf.2025.102642","DOIUrl":"10.1016/j.jchf.2025.102642","url":null,"abstract":"","PeriodicalId":14687,"journal":{"name":"JACC. Heart failure","volume":"13 11","pages":"Article 102642"},"PeriodicalIF":11.8,"publicationDate":"2025-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145089772","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
High NT-proBNP in Heart Failure 心力衰竭患者NT-proBNP偏高
IF 11.8 1区 医学
JACC. Heart failure Pub Date : 2025-09-15 DOI: 10.1016/j.jchf.2025.102650
Ahmed B. Shamsulddin MD
{"title":"High NT-proBNP in Heart Failure","authors":"Ahmed B. Shamsulddin MD","doi":"10.1016/j.jchf.2025.102650","DOIUrl":"10.1016/j.jchf.2025.102650","url":null,"abstract":"","PeriodicalId":14687,"journal":{"name":"JACC. Heart failure","volume":"13 11","pages":"Article 102650"},"PeriodicalIF":11.8,"publicationDate":"2025-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145061258","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mortality Across the Pre– and Post–Heart Transplant Continuum for Patients With Severe Obesity 重度肥胖患者心脏移植前后的死亡率。
IF 11.8 1区 医学
JACC. Heart failure Pub Date : 2025-09-11 DOI: 10.1016/j.jchf.2025.102651
Tae Kyung Yoo MD, MS , Rachael Steinhauer MD , Michael Wu BS, MPH , In-Cheol Kim MD, PhD , Jong-Chan Youn MD, PhD , Brian C. Downey MD , Indranee N. Rajapreyar MD , Amanda R. Vest MBBS, MPH
{"title":"Mortality Across the Pre– and Post–Heart Transplant Continuum for Patients With Severe Obesity","authors":"Tae Kyung Yoo MD, MS ,&nbsp;Rachael Steinhauer MD ,&nbsp;Michael Wu BS, MPH ,&nbsp;In-Cheol Kim MD, PhD ,&nbsp;Jong-Chan Youn MD, PhD ,&nbsp;Brian C. Downey MD ,&nbsp;Indranee N. Rajapreyar MD ,&nbsp;Amanda R. Vest MBBS, MPH","doi":"10.1016/j.jchf.2025.102651","DOIUrl":"10.1016/j.jchf.2025.102651","url":null,"abstract":"","PeriodicalId":14687,"journal":{"name":"JACC. Heart failure","volume":"13 11","pages":"Article 102651"},"PeriodicalIF":11.8,"publicationDate":"2025-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145043638","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Frailty Phenotype and Cardiovascular vs Noncardiovascular Mortality 虚弱表型和心血管与非心血管死亡率:左心室射血分数亚型的差异
IF 11.8 1区 医学
JACC. Heart failure Pub Date : 2025-09-11 DOI: 10.1016/j.jchf.2025.102654
Kensuke Ueno PhD, Kentaro Kamiya PhD, Koji Sakurada PhD, Tomoyuki Morisawa PhD, Masakazu Saitoh PhD, Michitaka Kato PhD, Yuji Kono PhD, Yuki Iida PhD, Tetsuya Takahashi PhD
{"title":"Frailty Phenotype and Cardiovascular vs Noncardiovascular Mortality","authors":"Kensuke Ueno PhD,&nbsp;Kentaro Kamiya PhD,&nbsp;Koji Sakurada PhD,&nbsp;Tomoyuki Morisawa PhD,&nbsp;Masakazu Saitoh PhD,&nbsp;Michitaka Kato PhD,&nbsp;Yuji Kono PhD,&nbsp;Yuki Iida PhD,&nbsp;Tetsuya Takahashi PhD","doi":"10.1016/j.jchf.2025.102654","DOIUrl":"10.1016/j.jchf.2025.102654","url":null,"abstract":"","PeriodicalId":14687,"journal":{"name":"JACC. Heart failure","volume":"13 11","pages":"Article 102654"},"PeriodicalIF":11.8,"publicationDate":"2025-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145043636","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Resting Hemodynamics and Prognosis in Heart Failure With Preserved Ejection Fraction 保留射血分数的心力衰竭的静息血流动力学和预后。
IF 11.8 1区 医学
JACC. Heart failure Pub Date : 2025-09-11 DOI: 10.1016/j.jchf.2025.102644
Selma F. Mohammed MD, PhD , Rosita Zakeri MBChB, PhD
{"title":"Resting Hemodynamics and Prognosis in Heart Failure With Preserved Ejection Fraction","authors":"Selma F. Mohammed MD, PhD ,&nbsp;Rosita Zakeri MBChB, PhD","doi":"10.1016/j.jchf.2025.102644","DOIUrl":"10.1016/j.jchf.2025.102644","url":null,"abstract":"","PeriodicalId":14687,"journal":{"name":"JACC. Heart failure","volume":"13 11","pages":"Article 102644"},"PeriodicalIF":11.8,"publicationDate":"2025-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145043635","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信